Follow
christine Brefel-courbon
christine Brefel-courbon
MCU PH, Neuropharmacologie, CHU Toulouse; TONIC (INSERM UT3); TMBI Univ Toulouse
Verified email at univ-tlse3.fr
Title
Cited by
Cited by
Year
Neurostimulation for Parkinson's disease with early motor complications
WMM Schuepbach, J Rau, K Knudsen, J Volkmann, P Krack, ...
New England Journal of Medicine 368 (7), 610-622, 2013
13102013
A Wide Variety of Mutations in the Parkin Gene Are Responsible for Autosomal Recessive Parkinsonism in Europe
N Abbas, CB Lücking, S Ricard, A Dürr, V Bonifati, G De Michele, ...
Human molecular genetics 8 (4), 567-574, 1999
6791999
Effect of levodopa on pain threshold in Parkinson's disease: a clinical and positron emission tomography study
C Brefel‐Courbon, P Payoux, C Thalamas, F Ory, I Quelven, F Chollet, ...
Movement disorders: official journal of the Movement Disorder Society 20 (12 …, 2005
3972005
Limitations of current Parkinson's disease therapy
O Rascol, P Payoux, F Ory, JJ Ferreira, C Brefel‐Courbon, JL Montastruc
Annals of Neurology: Official Journal of the American Neurological …, 2003
3702003
Levodopa raises objective pain threshold in Parkinson’s disease: a RIII reflex study
A Gerdelat-Mas, M Simonetta-Moreau, C Thalamas, F Ory-Magne, ...
Journal of Neurology, Neurosurgery & Psychiatry 78 (10), 1140-1142, 2007
2402007
Cardiac MIBG scintigraphy is a sensitive tool for detecting cardiac sympathetic denervation in Parkinson's disease
F Courbon, C Brefel‐Courbon, C Thalamas, MJ Alibelli, I Berry, ...
Movement disorders: official journal of the Movement Disorder Society 18 (8 …, 2003
2302003
Methylphenidate for gait hypokinesia and freezing in patients with Parkinson's disease undergoing subthalamic stimulation: a multicentre, parallel, randomised, placebo …
C Moreau, A Delval, L Defebvre, K Dujardin, A Duhamel, G Petyt, ...
The Lancet Neurology 11 (7), 589-596, 2012
1962012
Longitudinal analysis of impulse control disorders in Parkinson disease
JC Corvol, F Artaud, F Cormier-Dequaire, O Rascol, F Durif, ...
Neurology 91 (3), e189-e201, 2018
1912018
Clinical and imaging evidence of zolpidem effect in hypoxic encephalopathy
C Brefel‐Courbon, P Payoux, F Ory, A Sommet, T Slaoui, G Raboyeau, ...
Annals of neurology 62 (1), 102-105, 2007
1862007
α-Synuclein gene rearrangements in dominantly inherited parkinsonism: frequency, phenotype, and mechanisms
P Ibáñez, S Lesage, S Janin, E Lohmann, F Durif, A Destée, AM Bonnet, ...
Archives of neurology 66 (1), 102-108, 2009
1792009
Idazoxan, an alpha‐2 antagonist, and L‐DOPA‐induced dyskinesias in patients with Parkinson's disease
O Rascol, I Arnulf, H Peyro‐Saint Paul, C Brefel‐Courbon, M Vidailhet, ...
Movement disorders: official journal of the Movement Disorder Society 16 (4 …, 2001
1742001
Intracellular ferritin accumulation in neural and extraneural tissue characterizes a neurodegenerative disease associated with a mutation in the ferritin light polypeptide gene
R Vidal, B Ghetti, M Takao, C Brefel-Courbon, E Uro-Coste, BS Glazier, ...
Journal of Neuropathology & Experimental Neurology 63 (4), 363-380, 2004
1722004
Orthostatic hypotension in patients with Parkinson’s disease: pathophysiology and management
JM Senard, C Brefel-Courbon, O Rascol, JL Montastruc
Drugs & aging 18, 495-505, 2001
1572001
Origin of the mutations in the parkin gene in Europe: exon rearrangements are independent recurrent events, whereas point mutations may result from Founder effects
M Periquet, CB Lücking, JR Vaughan, V Bonifati, A Dürr, G De Michele, ...
The American Journal of Human Genetics 68 (3), 617-626, 2001
1542001
Withdrawing amantadine in dyskinetic patients with Parkinson disease: the AMANDYSK trial
F Ory-Magne, JC Corvol, JP Azulay, AM Bonnet, C Brefel-Courbon, ...
Neurology 82 (4), 300-307, 2014
1502014
Prediction of cognition in Parkinson's disease with a clinical–genetic score: a longitudinal analysis of nine cohorts
G Liu, JJ Locascio, JC Corvol, B Boot, Z Liao, K Page, D Franco, K Burke, ...
The Lancet Neurology 16 (8), 620-629, 2017
1372017
Does ageing influence deep brain stimulation outcomes in Parkinson's disease?
F Ory‐Magne, C Brefel‐Courbon, M Simonetta‐Moreau, N Fabre, ...
Movement disorders: official journal of the Movement Disorder Society 22 (10 …, 2007
1152007
Behavioural outcomes of subthalamic stimulation and medical therapy versus medical therapy alone for Parkinson's disease with early motor complications (EARLYSTIM trial …
E Lhommée, L Wojtecki, V Czernecki, K Witt, F Maier, L Tonder, ...
The Lancet Neurology 17 (3), 223-231, 2018
1142018
Sleep disruption, daytime somnolence and ‘sleep attacks’ in Parkinson's disease: A clinical survey in PD patients and age‐matched healthy volunteers
JJ Ferreira, K Desboeuf, M Galitzky, C Thalamas, C Brefel‐Courbon, ...
European journal of neurology 13 (3), 209-214, 2006
1102006
Sleep attacks and antiparkinsonian drugs: a pilot prospective pharmacoepidemiologic study
JL Montastruc, C Brefel-Courbon, JM Senard, H Bagheri, J Ferreira, ...
Clinical neuropharmacology 24 (3), 181-183, 2001
1102001
The system can't perform the operation now. Try again later.
Articles 1–20